VolitionRx Limited (VNRX) Stock Price

VNRXStock

$0.45−96.58%52W

Market Cap$6.48M

P/E—

PEG Ratio—

Div yield—

Beta1.15

VNRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-100.32%

Price vs S&P 500 (4W)-45.37%

VGM Score57.67

Book Value / Share (Quarterly)$0.07

P/TBV (Annual)9.49x

Revenue Growth (3Y)77.29%

Cash Flow / Share (Quarterly)$-2.62

Price vs S&P 500 (YTD)-104.03%

Net Profit Margin (TTM)-997.46%

EPS (TTM)$-4.22

10-Day Avg Trading Volume43.74M

EPS Excl Extra (TTM)$-4.22

Revenue Growth (5Y)180.21%

EPS (Annual)$-4.37

ROI (Annual)-122.64%

Net Profit Margin (5Y Avg)-9529.48%

Cash / Share (Quarterly)$0.39

Revenue Growth QoQ (YoY)299.81%

ROA (Last FY)-338.45%

Revenue Growth TTM (YoY)88.48%

EBITD / Share (TTM)$-3.65

ROE (5Y Avg)-136.80%

Operating Margin (TTM)-915.52%

Cash Flow / Share (Annual)$-3.14

P/B Ratio1.17x

P/B Ratio (Quarterly)18.58x

Net Income / Employee (Annual)$-311,400

EV / Revenue (TTM)6.30x

Net Interest Coverage (TTM)-8.44x

ROA (TTM)-316.46%

EPS Incl Extra (Annual)$-4.37

Current Ratio (Annual)0.17x

Quick Ratio (Quarterly)0.27x

3-Month Avg Trading Volume5.27M

52-Week Price Return-96.58%

Revenue / Employee (TTM)$32,900

Tangible BV / Share (Quarterly)$0.07

P/S Ratio (Annual)3.95x

Asset Turnover (Annual)0.25x

52-Week High$14.80

Operating Margin (5Y Avg)-9964.11%

EPS Excl Extra (Annual)$-4.37

CapEx CAGR (5Y)-45.94%

Tangible BV CAGR (5Y)-2.94%

26-Week Price Return-88.39%

Quick Ratio (Annual)0.13x

13-Week Price Return-84.40%

Total Debt / Equity (Annual)0.22x

Current Ratio (Quarterly)0.33x

Enterprise Value$15.54M

Revenue / Share Growth (5Y)338.27%

Asset Turnover (TTM)0.32x

Book Value / Share Growth (5Y)-16.26%

Revenue / Employee (Annual)$23,000

Pretax Margin (Annual)-1360.63%

Cash / Share (Annual)$0.18

3-Month Return Std Dev137.99%

Net Income / Employee (TTM)$-328,000

ROE (Last FY)-149.44%

Net Interest Coverage (Annual)-7.33x

EPS Basic Excl Extra (Annual)$-4.37

Receivables Turnover (TTM)11.21x

Total Debt / Equity (Quarterly)0.79x

EPS Incl Extra (TTM)$-4.22

Receivables Turnover (Annual)8.06x

ROI (TTM)-191.86%

P/S Ratio (TTM)2.76x

Pretax Margin (5Y Avg)-9606.40%

Revenue / Share (Annual)$0.32

Tangible BV / Share (Annual)$0.33

Price vs S&P 500 (52W)-115.14%

Year-to-Date Return-91.21%

5-Day Price Return14.91%

EPS Normalized (Annual)$-4.37

ROA (5Y Avg)-202.93%

Net Profit Margin (Annual)-1352.17%

Month-to-Date Return-37.43%

Cash Flow / Share (TTM)$-0.50

EBITD / Share (Annual)$-3.84

Operating Margin (Annual)-1258.47%

LT Debt / Equity (Annual)0.14x

ROI (5Y Avg)-107.56%

LT Debt / Equity (Quarterly)0.49x

EPS Basic Excl Extra (TTM)$-4.22

P/TBV (Quarterly)18.81x

P/B Ratio (Annual)9.37x

Pretax Margin (TTM)-1002.82%

Book Value / Share (Annual)$0.33

Price vs S&P 500 (13W)-86.35%

Beta1.15x

P/FCF (Annual)170.46x

Revenue / Share (TTM)$0.36

ROE (TTM)-376.59%

52-Week Low$0.33

vGradeB

gGradeA

mGradeF

vgmGradeC

VNRX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.67	-$0.59	+12.66%(+$0.08)
Q1 2026	May 14, 2026	-$0.73	-$0.84	-14.23%(-$0.10)
Q4 2025	Mar 31, 2026	-$0.80	-$0.91	-13.50%(-$0.11)
Q3 2025	Nov 13, 2025	-$1.04	-$1.06	-1.56%(-$0.02)
Q2 2025	Aug 14, 2025	-$1.00	-$1.31	-30.60%(-$0.31)

VNRX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.91

4.00

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
VNRXVolitionRx Limited	B	A	F	$0.45
IDXXIdexx Laboratories Inc	D	B	C	$554.99
LNTHLantheus Holdings, Inc	C	B	B	$100.77
CLDXCelldex Therapeutics, Inc	F	F	B	$39.12
NEOGNeogen Corp	C	C	B	$11.66
NTLAIntellia Therapeutics, Inc	D	D	C	$12.87
QDELQuidelOrtho Corporation Common Stock	C	C	C	$14.74
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.10
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	$7.12
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.67
MYGNMyriad Genetics Inc	B	C	D	$3.16
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.13
ICCCImmucell Corp	C	B	B	$9.94
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.35
TRIBTrinity Biotech plc	B	D	F	$9.68
BMRABIOMERICA INC	B	D	C	$2.14
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	D	$1.85
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	$2.82
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	B	$0.02

About VolitionRx Limited

VolitionRX Ltd develops blood-based diagnostic tests using its proprietary Nucleosomics platform to identify disease markers from circulating nucleosomes. The company's tests provide simple, cost-effective alternatives for diagnosing and monitoring cancers, sepsis, COVID-19, and other serious diseases. VolitionRX operates in both human and veterinary diagnostics, targeting underserved markets with accessible diagnostic solutions.